Modern View on the Problem of Choosing a Vaccine against Hepatitis B-Reference-Cited by-同舟云学术

Modern View on the Problem of Choosing a Vaccine against Hepatitis B

Published:2017-08-20 Issue:4 Volume:16 Page:65-72
ISSN:2073-3046
Container-title:Epidemiology and Vaccine Prevention
language:
Short-container-title:Epidemiology and Vaccine Prevention

Author:

Chulanov V. P.,Semenenko T. A.,Karandashova I. V.,Komarova S. V.,Kostyushev D. S.,Suslov A. P.,Volchkova E. V.

Abstract

The problem of the discrepancy between serotypes of the circulating strains of hepatitis B virus and serotype of the HBsAg in the vaccine is discussed. The results of published scientific studies show that hepatitis B vaccines containing HBsAg serotype ad provide good, but not optimal, protection against heterologous serotypes of the virus. The authors conclude that the use of vaccines containing HBsAg serotype typical for given territory is a priority. Further in-depth studies on this issue are needed to clarify the available scientific evidence.

Publisher

LLC Numicom

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Epidemiology

Reference52 articles.

1. Global hepatitis report, 2017. World Health Organization; 2017. Aviable at: http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/(15.04.2017).

2. World Health Organization. Fact sheet: Hepatitis B. Updated April 2017. Aviable at: http://www.who.int/mediacentre/factsheets/fs204/en/ (15.04.2017).

3. Pimenov N.N., Vdovin A.V., Komarova S.V., Mamonova N.A., Chulanov V.P, Pokrovsky V.I. Urgency and prospects for the introduction in Russia of a single federal register of patients with viral hepatitis B and C. Terapevtichesky arhiv. [Therapeutic archive]. 2013: 4 – 9 (in Russian).

4. On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2016: State report. Moscow: Rospotrebnadzor; 2017: 220 (in Russian).

5. Romano’ L., Paladini S., van Damme P., Zanetti A.R. The worldwide impact of vaccination on the control and protection of viral hepatitis B. Digestive and Liver Disease. 2011; 43: S2 – S7.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Russian Trivalent Hepatitis B Vaccine (Bubo®-Unigep): Reactogenicity, Safety and Immunological Efficacy;Epidemiology and Vaccinal Prevention;2024-07-10

2. New Russian Trivalent Hepatitis B Vaccine (Bubo<sup>®</sup>-Unigep): Clinical Study Results;Epidemiology and Vaccinal Prevention;2023-07-02

3. Current features of the epidemiology and prevention of hepatitis B in risk groups in Russian Federation;Sanitarnyj vrač (Sanitary Doctor);2021-11-13

4. Vaccine interchangeability: problems and prospects;BIOpreparations. Prevention, Diagnosis, Treatment;2021-10-02

5. National Association of Biobanks and Biobanking Specialists: New Community for Promoting Biobanking Ideas and Projects in Russia;Biopreservation and Biobanking;2021-02-01